Located in Washington, DC, Dr. Anderson obtained his B.A. in Physics from Yale and a Ph.D. in Molecular Biology from Cambridge University. His primary scientific interest is in the human plasma proteome, and its use for longitudinal health monitoring. He received the 2009 HUPO Distinguished Achievement Award in Proteomic Science. He co-founded Large Scale Biology, (co-leading its IPO in 2000), and has served as a Director of three NASDAQ companies including Dade Behring (a global diagnostics company).
“The future demands major improvements in access to diagnostic testing, particularly longitudinal biomarker tracking with personalized interpretation. Frequent self-collected samples are a key component of this future.”